Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens

We examined the real-world utilization and persistence of rapid acting insulin (RAI) in elderly patients with type 2 diabetes who added RAI to their drug (OAD) regimen. Insulin-naïve patients aged ≥65 years, with ≥1 OAD prescription during the baseline period, who were continuously enrolled in the U...

Descripción completa

Detalles Bibliográficos
Autores principales: Sambamoorthi, Usha, Deb, Arijita, Zhou, Steve, Garg, Rahul, Fan, Tao, Boss, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059557/
https://www.ncbi.nlm.nih.gov/pubmed/27761472
http://dx.doi.org/10.1155/2016/5374931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059557/
https://www.ncbi.nlm.nih.gov/pubmed/27761472
http://dx.doi.org/10.1155/2016/5374931

Ejemplares similares